C. Wang et al. / Dyes and Pigments 98 (2013) 464e470
467
of DMF and 0.4 mL of phosphorus oxychloride were added quickly
and then the mixture was kept at 85 ꢀC for 24 h. After neutralization
with 25% NaOH solution, the mixture was extracted with
dichloromethane and washed with water. The organic solution was
dried over anhydrous MgSO4, and then the solvent was removed by
rotary evaporation. The crude product was purified by silica gel
column chromatography using petroleum ether/dichloromethane
(1:1, v:v) as eluent and dried under vacuum to give 0.18 g 2 as a
(5-tetradecylthiophen-2-yl)thiophen-2-yl)benzo[c][1,2,5]thiadia-
zol-4-yl)thiophene-2-carbaldehyde (0.80 g, 1.03 mmol) and po-
tassium tertbutoxide (0.12 g, 1.03 mmol). The crude product was
purified by silica gel column chromatography using petroleum
ether/dichloromethane (3:2, v:v) as eluent to give 0.35 g 3 as a red
n
solid (Yield: 47.9%). FT-IR (KBr, cmꢁ1): 945( C]C). 1H NMR
(400 MHz, CDCl3,
d
/ppm): 8.00e7.97 (d, J ¼ 11.6 Hz, 4H); 7.80 (s,
4H), 7.61 (s, 2H), 7.26 (s, 4H), 7.04e7.03 (d, J ¼ 3.1 Hz, 2H); 6.77e6.76
(d, J ¼ 2.7 Hz, 2H); 3.78e3.77 (m, 2H); 2.85e2.77 (m, 12H); 1.92e
1.89 (m, 1H); 1.73e1.72 (m, 12H); 1.45e1.27 (m, 72H); 1.11e1.08
(t, J ¼ 7.3 Hz, 4H); 0.93e0.86 (m, 24H). 13C NMR (CDCl3, 100 MHz,
purple-red solid (Yield: 56.3%). FT-IR (KBr, cmꢁ1): 1655 (
C]C). 1H NMR (400 MHz, CDCl3,
/ppm): 10.10 (s, 2H), 8.08e8.07
nC]O), 952
(n
d
(d, J ¼ 3.6 Hz, 4H); 7.98e7.97 (m, 2H); 7.87e7.86 (d, J ¼ 7.6 Hz, 2H);
7.68 (s, 2H); 7.52e7.50 (d, J ¼ 8.4 Hz, 2H); 7.41e7.39 (d, J ¼ 5.7 Hz,
2H); 7.15e7.06 (m,10H); 3.84e3.83 (m, 2H); 3.06e3.02 (t, J ¼ 7.6 Hz,
4H); 2.82e2.78 (t, J ¼ 7.6 Hz, 4H); 2.34e2.31 (m, 6H); 1.96e1.93 (m,
1H); 1.82e1.72 (m, 12H); 1.57e1.26 (m, 22H); 1.12e1.09 (t,
d/ppm): 153.70,152.48,146.31,142.97,139.73,137.78,137.22,136.30,
133.61, 133.42, 133.00, 130.50, 130.31, 126.89, 125.57, 125.39, 125.15,
125.10, 124.73, 124.41, 121.32, 121.08, 117.41, 100.03, 78.27, 41.13,
31.95, 31.83, 31.75, 31.61, 31.00, 30.91, 30.53, 30.21, 29.72, 29.68,
29.63, 29.57, 29.43, 29.40, 29.37, 29.32, 29.25, 28.70, 24.05, 23.40,
22.73, 22.70, 14.35, 14.16, 14.10, 11.89, 1.02. MALDI-TOF MS
(C106H145BrN4OS8) m/z: calcd for 1827.736; found 1827.219.
J ¼ 7.2 Hz, 6H); 0.91e0.89 (m, 18H). 13C NMR (CDCl3, 100 MHz,
d/
ppm): 181.96, 181.88, 154.23, 153.24, 152.50, 152.39, 147.79, 147.45,
145.29, 142.63, 139.57, 137.35, 136.90, 136.15, 133.81, 132.73, 132.69,
131.51, 131.37, 130.85, 130.83, 130.30, 129.98, 129.93, 128.86, 128.82,
127.72, 127.67, 127.61, 127.15, 124.80, 124.73, 124.59, 123.96, 123.70,
123.69, 123.49, 123.47, 122.72, 122.68, 120.66, 78.37, 74.79, 74.74,
74.68, 68.53, 47.73, 47.68, 47.64, 47.62, 47.58, 41.14, 31.93, 31.77,
31.61, 31.42, 30.95, 29.70, 29.35, 29.21, 29.10, 28.71, 28.66, 24.13,
23.39, 22.66, 22.59, 21.14, 20.82, 20.78, 19.25, 19.23, 14.31, 14.10,
14.04, 11.83. MALDI-TOF MS (C92H103N5O3S6) m/z: calcd for
1518.641; found 1518.725.
2.4.6. Synthesis of TPA-DTBT-TH
TPA-DTBT-TH was synthesized according to compound TPA-
DTBT, instead using compound 3 (0.30 g, 0.16 mmol), 4-methyl-
N-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-N-p-
tolylbenzenamine (0.098 g, 0.25 mmol) and anhydrous K2CO3
(0.032 g, 0.23 mmol). The crude product was purified by silica gel
column chromatography using petroleum ether/dichloromethane
(3:1, v:v) as eluent to give 0.15 g TPA-DTBT-TH as a dark red solid
2.4.4. Synthesis of compound TPA-DTBT-CAO
n
(Yield: 45.3%). FT-IR (KBr, cmꢁ1): 951 ( C]C). 1H NMR (400 MHz,
Compound 2 (0.10 g, 0.066 mmol), 2-ethylhexyl cyanoacetate
(0.52 g, 2.63 mmol), and piperidine (1.0 mL) were dissolved in
CHCl3 (20 mL) and CH3CN (40 mL), and the solution was refluxed at
80 ꢀC for 12 h under nitrogen atmosphere. Then the solution was
poured into a diluted aqueous HCl (10 mL) solution and extracted
with dichloromethane. The organic phase was dried over anhy-
drous MgSO4, and the solvent was removed by rotary evaporation.
The crude product was purified by silica gel column chromatog-
raphy using petroleum ether/dichloromethane (1:1, v:v) as eluent
to give 0.07 g TPA-DTBT-CAO as a purple-red solid (Yield: 56.6%).
CDCl3, /ppm): 8.03 (s, 2H), 7.98 (s, 2H), 7.82 (s, 4H), 7.67 (s, 2H),
d
7.52e7.50 (d, J ¼ 8.3 Hz, 2H); 7.39 (s, 4H), 7.15e7.04 (m, 12H); 6.77e
6.76 (d, J ¼ 3.0 Hz, 2H); 3.84e3.83 (m, 2H); 2.85e2.77 (m, 12H);
2.34 (s, 6H), 1.96e1.93 (m, 1H); 1.74e1.74 (m, 12H); 1.45e1.27 (m,
72H); 1.12e1.08 (t, J ¼ 7.3 Hz, 4H); 0.91e0.88 (m, 24H). 13C NMR
(CDCl3, 100 MHz, d/ppm): 154.22, 154.20, 152.67, 152.64, 147.73,
147.72, 146.49, 146.44, 145.36, 142.58, 142.55, 139.89, 139.85, 138.47,
136.99, 136.92, 136.80, 136.47, 134.08, 133.59, 133.56, 133.10, 133.07,
132.67, 131.56, 130.68, 130.63, 129.98, 127.68, 125.72, 125.69, 125.49,
125.45,125.29,125.05,125.02,124.77,124.47,123.45,123.30,122.79,
120.96, 78.30, 41.15, 31.97, 31.81, 31.79, 31.76, 31.74, 31.63, 31.01,
30.97, 30.60, 30.23, 29.72, 29.71, 29.70, 29.63, 29.61, 29.58, 29.44,
29.41, 29.39, 29.38, 29.34, 29.24, 29.21, 28.72, 24.15, 23.40, 23.36,
22.70, 22.67, 20.85, 14.32, 14.27, 14.12, 11.82, 11.76, 1.04. Calcd for
C90H103N5O2S6: C, 74.91; H, 8.13; N, 3.47; S, 12.70. Found: C, 74.84;
H, 8.28; N, 3.62; S,12.79. MALDI-TOF MS (C126H163N5OS8) m/z: calcd
for 2019.065; found 2019.181.
FT-IR (KBr, cmꢁ1): 2214 (
nC^N), 1720 (nC]OOR), 949(n
C]C). 1H NMR
(400 MHz, CDCl3, /ppm): 8.46 (s, 2H), 8.20 (s, 2H), 8.07 (s, 2H),
d
8.02e8.01 (d, J ¼ 7.8 Hz, 2H); 7.87e7.85 (d, J ¼ 7.7 Hz, 2H); 7.68 (s,
2H); 7.52e7.50 (d, J ¼ 8.4 Hz, 2H); 7.41e7.39 (m, 2H); 7.15e7.05 (m,
12H); 4.25e4.24 (m, 4H); 3.85e3.83 (d, J ¼ 4.9 Hz, 2H); 2.91e2.87
(t, J ¼ 7.5 Hz, 4H); 2.81e2.77 (t, J ¼ 7.5 Hz, 4H); 2.34e2.30 (m, 6H);
1.97e1.94 (m, 1H); 1.73e1.72 (m, 10H); 1.45e1.35 (m, 32H); 1.14e
1.10 (t, J ¼ 7.4 Hz, 6H); 0.98e0.89 (m, 30H). 13C NMR (CDCl3,
100 MHz,
d
/ppm): 163.56, 155.65, 154.28, 152.47, 152.39, 147.78,
3. Results and discussion
147.57, 145.30, 143.62, 142.63, 139.83, 136.82, 136,16, 133.85, 132.72,
131.61, 131.35, 130.85, 130.75, 129.97, 129.89, 129.86, 128.86, 127.86,
127.67, 127.60, 124.80, 124.63, 124.57, 123.75, 123.49, 123.42, 123.00,
122.70, 120.52, 116.20, 110.02, 96.93, 78.46, 69.51, 68.78, 68.52,
65.53, 49.05, 41.14, 38.97, 38.77, 35.20, 31.77, 31.59, 31.46, 31.34,
30.95, 30.86, 30.63, 30.50, 30.32, 30.30, 29.68, 29.27, 29.23, 29.14,
29.06, 28.88, 28.67, 24.10, 23.94, 23.71, 23.34, 22.98, 22.92, 22.66,
22.59, 22.55, 20.82, 20.77, 19.20, 14.32, 14.10, 14.01, 13.68, 11.88,
11.45, 11.07, 10.89. Calcd for C90H103N5O2S6: C, 72.92; H, 7.35; N,
5.22; S, 10.25. Found: C, 72.84; H, 7.48; N, 5.62; S, 10.79. MALDI-TOF
MS (C114H137N7O5S6) m/z: calcd for 1877.742; found 1877.004.
3.1. Synthesis and characterization
The detailed synthetic routes of TPA-DTBT, TPA-DTBT-TH and
TPA-DTBT-CAO are shown in Scheme 1. All of three organic small
molecules were prepared according to several classical reactions.
First, the compound 1 and 3 were obtained from 5-bromo-1,3-
bis(diethyl-phsophonate-methyl)-2-(ethylhexyl)benzene by Wit-
tigeHorner reaction with (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-
2-yl)phenyl)-N-p-tolylbenzenamine or 3-hexyl-5-(7-(4-hexyl-5-
(5-tetradecylthiophen-2-yl)thiophen-2-yl)benzo[c][1,2,5]-thiadia-
zol-4-yl)thiophene-2-carbaldehyde in THF, respectively. The TPA-
DTBT and TPA-DTBT-TH were synthesized by Suzuki coupling re-
action, which were synthesized from 4-methyl-N-(4-(4,4,5,5-
tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-N-p-tolylbenzen-amine
and compound 1 or 3 with Pd(PPh3)4 as the catalyst in a biphasic
mixture of aqueous K2CO3 and toluene with yields of 55.3% and
45.3%, respectively. Then the compound 2 was obtained from
2.4.5. Synthesis of 3-hexyl-5-(7-(4-hexyl-5-(5-tetradecylthiophen-
2-yl)thiophen-2-yl) benzo[c][1,2,5]thiadiazol-4-yl)thiophene-2-
carbaldehyde (3)
Compound
3 was synthesized according to compound 1,
instead using 5-bromo-1,3-bis(diethyl-phsophonate-methyl)-2-
(ethylhexyl)benzene (0.24 g, 0.4 mmol), 3-hexyl-5-(7-(4-hexyl-5-